A mathematical model for the transport of paclitaxel (Taxol) across the blood-brain barrier

Chemical Engineering Research and Design

Volumn 85, Issue 7 A, 2007, Pages 1065-1071

  Bandara, S ^a,c   Diehl, M ^b   Fricker, G ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c STANFORD UNIVERSITY   (United States)

Author keywords

Blood brain barrier; Drug transport; Paclitaxel; Parameter estimation

Indexed keywords

BRAIN; DIFFUSION; DRUG PRODUCTS; ENDOTHELIAL CELLS; MATHEMATICAL MODELS; ONCOLOGY; ORDINARY DIFFERENTIAL EQUATIONS; TRANSPORT PROPERTIES;

ANTIMITOTIC DRUG; BLOOD-BRAIN BARRIER; BRAIN CAPILLARY; PASSIVE DIFFUSION;

DRUG DELIVERY;

BRAIN; DIFFUSION; DRUG DELIVERY; DRUG PRODUCTS; ENDOTHELIAL CELLS; MATHEMATICAL MODELS; ONCOLOGY; ORDINARY DIFFERENTIAL EQUATIONS; TRANSPORT PROPERTIES;

EID: 34547816195     PISSN: 02638762     EISSN: None     Source Type: Journal    
DOI: 10.1205/cherd06238     Document Type: Article

References (24)

1. Ball, E.G. and Cooper, O., 1952, The reaction of cytochrome oxidase with cyanide, J Biol Chem, 198: 629-638.
2. Bock, H.G., 1987, Randwertproblemmethoden zur Parameteridentifizierung in Systemen nichtlinearer Differentialgleichungen, in Bonner Mathematische Schriften (Vol. 3) (Universität Bonn, Bonn, Germany).
3. Caplow, M., Shanks, J. and Ruhlen, R., 1994, How Taxol modulates microtubule disassembly, J Biol Chem, 269: 23399-23402.
4. Chang, E.L., 1994, Unusual thermal stability of liposomes made from bipolar tetraether lipids, Biochem Biophys Res Commun, 202: 673-679.
5. Dermietzel, R., 1975, Junctions in the central nervous system of the cat. Part IV: Interendothelial junctions of cerebral blood vessels from selected areas of the brain, Cell Tissue Res, 164: 45-62.
6. Diehl, M., 2002, Real-time optimization for large scale nonlinear processes, in Fortschr.-Ber. VDI Reihe 8, Meß-, Steuerungs- und Regelungstechnik, (vol 920) (VDI Verlag, Düsseldorf, Germany). Available at: http://www.ub.uni-heidelberg.de/archiv/1659/.
7. Eisenblatter, T., Huwel, S. and Galla, H.J., 2003, Characterization of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier, Brain Res, 971: 221-231.
8. Fellner, S., Bauer, B., Miller, D.S., Schaffrik, M., Frankhänel, M., Spruß, T, Bernhardt, G., Graeff, C., Färber, L., Gschaidmeier, H., Buschauer, A. and Fricker, G., 2002, Transport of paclitaxel (taxol) across the blood-brain barrier in vitro and in vivo, J Clin Invest,, 110: 1309-1318.
9. Glantz, M.J., Chamberlain M.C., Chang, S.M., Prados, M.D. and Cole, B.F., 1999, The role of paclitaxel in the treatment of primary and metastatic brain tumours, Semin Radiat Oncol, 9: 27-33.
10. Heimans, J.J., Vermorken, J.B., Wolbers, J.G., Eeltink C.M., Meijer, O.W., Taphoorn, M.J. and Beijnen, J.H., 1994, Paclitaxel (taxol) concentrations in brain tumor tissue, Ann Oncol, 5: 951-953.
11. Henningsson, A., Karlsson, M.O., Viganò, L., Gianni, L., Verweij, J. and Sparreboom, A., 2001, Mechanism-based pharmacokinetic model for paclitaxel, J Clin Oncol, 19: 4065-4073.
12. Jang, S.H., Wientjes, M.G. and Au, J.L., 2001, Kinetics of p-glycoprotein-mediated efflux of paclitaxel, J Pharmacol Exp Ther, 298: 1236-1242.
13. Juliano, R.L. and Ling, V., 1976, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants, Biochim Biophys Acta, 455: 152-162.
14. Kallrath, J., Bock, H.G. and Schlöder, J.P., 1993, Least squares parameter estimation in chaotic differential equations, Celest Mech Dyn Astro, 56: 353-371.
15. Leineweber, D.B., Schäfer, A., Bock, H.G. and Schlöder, J.P., 2003, An efficient multiple shooting based reduced SQP strategy for large-scale dynamic process optimization. Part II: Software aspects and applications, Comp Chem Eng, 27: 167-174.
16. Maggon, K., 2005, Best-selling human medicines 2002-2004, Drug Discov Today, 10: 739-742.
17. Martin, C., Berridge, G., Higgins C.F., Mistry, P., Charlton, P. and Callaghan, R., 2000, Communication between multiple drug binding sites on p-glycoprotein, Mol Pharmacol, 58: 624-632.
18. Melan, M.A., 1998, Use of fluorochrome-tagged taxol to produce fluorescent microtubules in solution, Biotechniques, 25: 188-192.
19. Rasband, W.S., 1997-2006, ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA. Available at http://rsb.info.nih.gov/ij/.
20. Rowinsky, E.K., 1997, Paclitaxel pharmacology and other tumor types, Semin Oncol, 24: S19-1-12.
21. Schinkel, A.H., Wagenaar, E., Mol, C.A. and van Deemter, L., 1996, P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs, J Clin Invest, 97: 2517-2524.
22. Seetharaman, S., Barrand, M.A., Maskell, L. and Scheper, R.J., 1998, Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates, J Neurochem, 70: 1151-1159.
23. Steiner, H.H., Herold-Mende, C., Bonsanto, M., Geletneky, K. and Kunze, S., 1998, Prognosis of brain tumours: epidemiology, survival time, and clinical course, Versicherungsmedizin, 50: 173-179.
24. Thöle, M., Nobmann, S., Huwyler, J., Bartmann, A. and Fricker, G., 2002, Uptake of cationized albumin coupled liposomes by cultured porcine brain microvessel endothelial cells and intact brain capillaries, J Drug Target, 10: 337-344.